Horizon Two: HR NDMM (MMRC-100)
for High Risk Newly Diagnosed Multiple Myeloma
7 locations incl. Atlanta
Sponsor: Multiple Myeloma Research Consortium
Sex: All·Age: 18+
Code: NCT07053436·Phase 2·Recruiting·Listed Jul 2025
Duplicate_University of Chicago Medicine
Clinical research site in Chicago, Illinois · 5841 S MARYLAND AVE, CHICAGO, IL 60637-1447 · (773) 926-1193 · Website
As of July 2026, 3 paid clinical trials are recruiting at Duplicate_University of Chicago Medicine in Chicago, Illinois. Active studies at this site cover conditions such as High Risk Newly Diagnosed Multiple Myeloma, BRCA1 Gene Mutation and BRCA2 Gene Mutation. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Duplicate_University of Chicago Medicine (3)
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
for BRCA1 Gene Mutation
11 locations incl. Chicago
Sponsor: University Medical Center Nijmegen
Sex: Female·Age: 25 - 50
Code: NCT04294927·Recruiting·Listed Mar 2020
Forceps vs. Snare IVC Filter Removal
for DVT
1 location in Chicago
Sponsor: University of Chicago
Sex: All·Age: 18+
Code: NCT04092192·Recruiting·Listed Sep 2019
More research sites in Chicago
- Northwestern University (341 trials)
- University of Chicago (182 trials)
- Rush University Medical Center (151 trials)
- Ann & Robert H. Lurie Children's Hospital of Chicago (113 trials)
- University of Chicago Medical Center (98 trials)
- Northwestern Memorial Hospital (87 trials)
- University of Chicago Comprehensive Cancer Center (87 trials)
- University of Illinois (84 trials)
- University of Illinois at Chicago (72 trials)
- Advocate Illinois Masonic Medical Center (50 trials)
Explore more
Paid clinical trials in Chicago, IL · Illinois clinical trials